Literature DB >> 15877892

Prebiotics and resistance to gastrointestinal infections.

G R Gibson1, A L McCartney, R A Rastall.   

Abstract

Acute gut disorder is a cause for significant medicinal and economic concern. Certain individual pathogens of the gut, often transmitted in food or water, have the ability to cause severe discomfort. There is a need to manage such conditions more effectively. The route of reducing the risk of intestinal infections through diet remains largely unexplored. Antibiotics are effective at inhibiting pathogens; however, these should not be prescribed in the absence of disease and therefore cannot be used prophylactically. Moreover, their indiscriminate use has reduced effectiveness. Evidence has accumulated to suggest that some of the health-promoting bacteria in the gut (probiotics) can elicit a multiplicity of inhibitory effects against pathogens. Hence, an increase in their numbers should prove effective at repressing pathogen colonisation if/when infectious agents enter the gut. As such, fortification of indigenous bifidobacteria/lactobacilli by using prebiotics should improve protection. There are a number of potential mechanisms for lactic acid bacteria to reduce intestinal infections. Firstly, metabolic endproducts such as acids excreted by these micro-organisms may lower the gut pH to levels below those at which pathogens are able to effectively compete. Also, many lactobacilli and bifidobacteria species are able to excrete natural antibiotics, which can have a broad spectrum of activity. Other mechanisms include an improved immune stimulation, competition for nutrients and blocking of pathogen adhesion sites in the gut. Many intestinal pathogens like type 1 fimbriated Escherichia coli, salmonellae and campylobacters utilise oligosaccharide receptor sites in the gut. Once established, they can then cause gastroenteritis through invasive and/or toxin forming properties. One extrapolation of the prebiotic concept is to simulate such receptor sites in the gut lumen. Hence, the pathogen is 'decoyed' into not binding at the host mucosal interface. The combined effects of prebiotics upon the lactic acid flora and anti-adhesive strategies may lead towards new dietary interventions against food safety agents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15877892     DOI: 10.1079/bjn20041343

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  44 in total

Review 1.  Pathogen-induced secretory diarrhea and its prevention.

Authors:  S Anand; S Mandal; P Patil; S K Tomar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-29       Impact factor: 3.267

2.  Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells.

Authors:  Kari Shoaf; George L Mulvey; Glen D Armstrong; Robert W Hutkins
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

3.  Adherence inhibition of Cronobacter sakazakii to intestinal epithelial cells by prebiotic oligosaccharides.

Authors:  Maria Quintero; Maria Maldonado; Mariaelisa Perez-Munoz; Roberto Jimenez; Terry Fangman; John Rupnow; Anja Wittke; Michael Russell; Robert Hutkins
Journal:  Curr Microbiol       Date:  2011-02-04       Impact factor: 2.188

4.  Identification of prebiotic fructooligosaccharide metabolism in Lactobacillus plantarum WCFS1 through microarrays.

Authors:  Delphine M A Saulnier; Douwe Molenaar; Willem M de Vos; Glenn R Gibson; Sofia Kolida
Journal:  Appl Environ Microbiol       Date:  2007-01-19       Impact factor: 4.792

5.  Inter-species differences in the growth of bifidobacteria cultured on human milk oligosaccharides.

Authors:  Sarka Rockova; Vojtech Rada; Jiri Nevoral; Petr Marsik; Eva Vlkova; Vera Bunesova
Journal:  Folia Microbiol (Praha)       Date:  2012-04-11       Impact factor: 2.099

6.  Efficient recombinant expression and secretion of a thermostable GH26 mannan endo-1,4-beta-mannosidase from Bacillus licheniformis in Escherichia coli.

Authors:  Chomphunuch Songsiriritthigul; Bancha Buranabanyat; Dietmar Haltrich; Montarop Yamabhai
Journal:  Microb Cell Fact       Date:  2010-04-11       Impact factor: 5.328

Review 7.  Do you have a probiotic in your future?

Authors:  Maria G Dominguez-Bello; Martin J Blaser
Journal:  Microbes Infect       Date:  2008-08-13       Impact factor: 2.700

8.  Differential transcriptional response of Bifidobacterium longum to human milk, formula milk, and galactooligosaccharide.

Authors:  Rina González; Eline S Klaassens; Erja Malinen; Willem M de Vos; Elaine E Vaughan
Journal:  Appl Environ Microbiol       Date:  2008-06-06       Impact factor: 4.792

9.  Comparative in vitro inhibition of urinary tract pathogens by single- and multi-strain probiotics.

Authors:  C M C Chapman; G R Gibson; S Todd; I Rowland
Journal:  Eur J Nutr       Date:  2013-02-08       Impact factor: 5.614

10.  Construction of 12 EST libraries and characterization of a 12,226 EST dataset for chicory (Cichorium intybus) root, leaves and nodules in the context of carbohydrate metabolism investigation.

Authors:  Nicolas Dauchot; Dominique Mingeot; Bénédicte Purnelle; Céline Muys; Bernard Watillon; Marc Boutry; Pierre Van Cutsem
Journal:  BMC Plant Biol       Date:  2009-01-28       Impact factor: 4.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.